【Philips Japan Co., Ltd.】 Heart safe city aiming at realization of the world’s number one recovery rate from cardiopulmonary arrest, National cardiovascular disease research center and Philips start efforts in North Osaka health care city (Kento)
Philips Japan Ltd. Heart safe city aiming at realization of the world’s top recovery rate from cardiopulmonary arrest, National Cardiovascular Disease Research Center and Philips start efforts in North Osaka health care city (kento) Kento Heart safe city project ………………………………………………………………………………………… The National Cardiovascular Disease Research Center (Suita City, Osaka Prefecture, President: Hisao Ogawa, “Kokukyu”) and Philips Japan Co., Ltd. (Head office: Minato-ku, Tokyo, President and CEO: Hiroyuki Tsutsumi, “below “Philips”) will report on the start of the Kento Heart safe city project while utilizing the resources that both sides have strengths. Heart safe city promotes appropriate placement of AED, fostering and support for first responders (helpers who can properly take first-aid treatment until they take over to emergency services), and create a system with government, local governments and local companies, and from cardiorespiratory arrest Work to achieve the world’s No. 1 reintegration rate. Record 1. Name: “National Cardiovascular Research Center and by Philips Town development aiming at realization of the world’s number one return rate from cardiopulmonary arrest, Kento Heart safe city project ” 2. Venue: National Cardiovascular Research Center Open Innovation Center 4F Science Cafe (6-5, Kishibe Shinmachi, Suita City, Osaka Prefecture 564-8565) 3. Date and time: Saturday, July 6, 2019 11: 00-12: 00 (reception start: 10: 30-) 4. Attendees: National Cardiovascular Research Center Deputy Director Atsushi Yasuda Kunihiro Nishimura General Manager, Preventive Medicine and Epidemiology Information Division Cardiovascular Internal Medicine Chief Doctor Yoshio Tahara Philips Japan Ltd. President Hiroyuki Tsutsumi 5. Presentation: (1) The heart safe city concept realized by the Health Tech Company / President of Philips Tsutsumi (2) Significance of the Kento Heart safe city project in collaboration with industry, government, and academia (3) Significance of the Kento Heart safe city project from the viewpoint of statistical and epidemiological research (4) Specific contents of the project’s activities (5) Guest Representative greetings / Settsu City Mayor Moriyama Kazumasa (6) Guest Representative Greeting / Suita City Mayor of Goto Gotoh (7) Photo session + questions and answers By strategic alliance between National Cardiovascular Research Center and Philips “Town development aiming at realization of social recovery rate” the best in the world “from cardiopulmonary arrest” NCVC and Philips Kento Heart safe city project 【background】 The rate of reintegration from cardiopulmonary arrest in Japan is not always high, and there is still room for improvement. In addition to proper placement of the AED, this depends on whether people at the site understand how to operate the AED and can take a step to save life. [Point of approach] 1. Create a system with government, local governments, and local companies ・ Heart safe city can not be realized without the cooperation of the administration or local government in the issue of personal information and participation in local residents. The underlying thing is the connection with people in the area, and the connection produces self-help and mutual support. While various organizations play their respective roles, it is essential to recognize and collaborate as the value of a new town. ・ In this project, Suita City, Settsu City, Municipal Suita City Hospital, West Japan Passenger Railway Co., Ltd., JR West Japan Real Estate Development Co., Ltd., Kintetsu Real Estate Co., Ltd., Daiwa House Industry Co., Ltd. Meitetsu Real Estate Co., Ltd., Kintetsu Housing Management Co., Ltd., Donald McDonald House Charities Japan, etc. will work to create a collaborative system. 2. Significance of collaboration between National Cardiovascular Research Center and Philips ・ As a national center of Japan, the National Cardiovascular Disease Research Center working on prevention, treatment, research, etc. aiming to overcome cardiovascular disease daily for the health and well-being of the people, and a healthy life as a health technology company, A combination of two Philips providing cardiology (cardiac disease) solutions in all areas, covering a series of health care processes (Health Continuum): prevention, diagnosis, treatment, home care In this way, we will develop this model to the whole country and the whole world to disseminate it through our town development efforts in Kento. 3. Lifesaving / first aid assistance smartphone application “MySOS” * button ・ Philips already has the link between IoT technology and apps to enable simultaneous notification to the people who need it in a wider range. In this way, it becomes possible to create a system that strengthens self-help and mutual support in each organization, including the relief system for large-scale events where many people gather. * MySOS is a trademark or registered trademark of Arum Co., Ltd. Features LTE-M communication standard Easy to install SOS button Setting range of notification to rescuer possible Simultaneous notification is possible in 10 seconds from button press [Image
【the next deployment】 As the development of this project, we will contribute to the relief system for mass gathering events with a large number of visitors, such as the 2025 Japan International Expo (Osaka-Kansai World Exposition) and sports. In addition, through cooperation with local government, administration, related companies, community development conscious of local connection that heat stroke measures and self-help, mutual assistance increase of alone elderly people who are not only cardiopulmonary arrest through cooperation mechanism and sustainable education system for cardiopulmonary arrest. We will co-create a society that contributes to health, prevention and medical treatment. National Cardiovascular Research Center 564-8565 6-1 Kishibe Shinmachi, Suita City, Osaka Prefecture President Hisao Ogawa Philips Japan Ltd. 108-8507 2 9-37 Konan, Minato Ward, Tokyo Prefecture Philips Building President Hiroyuki Tsutsumi About National Cardiovascular Research Center Opened in June 1977 and started medical treatment and research in August, it is one of the world’s leading national centers dedicated to the highly specialized care of stroke and heart disease patients. There are three basic principles of the national circulation. The first is aiming at an international base for the prevention and control of cardiovascular disease, the second is leading the world in the development of cutting-edge medicine and medical technology through open innovation, and the third is a surrounding area linked to open innovation In order to form an international-class integrated medical industry base “medical cluster” by Relocated to Kita-Osaka Health and Medical City (Kento) in July 2019, and a new nation circulation was born. The new center will be equipped with state-of-the-art medical equipment such as gamma knife, PET, cyclotron, etc. and medical equipment to cope with various cardiovascular diseases. Furthermore, in the new center, all organizations under one roof, not only internal collaboration, but also knowledge and technology at the Open Innovation Center (OIC), which conducts joint research with researchers from companies and universities, etc. We will gather and advance research. In this major medical cluster, “hospital,” “research lab,” “OIC,” and regions will be united to promote initiatives for new treatment methods related to cardiovascular disease in Japan. About Philips Founded in the Netherlands in 1891 and utilizing technology and knowledge gained through business model transformation and a long history, we have realized innovation in a “series of healthcare processes” of healthy living, prevention, diagnosis, treatment and home care Health care company. Philips Japan (formerly Philips Electronics Japan) has been integrated with Philips Respironics as a health technology company since April 1, 2019, in an effort to contribute to the health and medical problems of Japan, which is facing an aging society. We are working on changing the care field. In the future, Philips’ advanced medical equipment in the professional field of “hospital”, oral health care (electric toothbrush) called personal health, AED, home respirator, etc. will be connected on the cloud, and big data will be analyzed on digital platform Enables comprehensive medical care, real-time analysis and value-added services It becomes. This will provide innovative medical solutions in the “series of health care processes” of people’s healthy life, prevention, diagnosis, treatment and home care. We aim to contribute to the healthy life of people. (Https://www.philips.co.jp) About Royal Phillips Royal Phillips (NYSE: PHG, AEX: PHI) is a leading company in the field of health technology that contributes to the improvement of people’s health with technology. Through a series of health care processes of healthy living, prevention, diagnosis, treatment, and home care, we improve people’s health and bring good results based on advanced technology and healthcare professionals and consumers’ insights. Provides a comprehensive solution for The main business areas are imaging diagnosis, image guided therapy, biomedical information monitor, health informatics, as well as various areas such as personal health and home care. With sales of € 17.4 billion in 2016 for the Philips Healthtech business and 71,000 employees worldwide based in the Netherlands, the company operates in more than 100 countries worldwide. See news about Philips here. ( http://www.philips.com/newscenter/)
For more information about this release(Japanese):
Comment ( 0 )
Trackbacks are closed.